Total Payments
$23,008
2024 Payments
$7,841
Companies
10
Transactions
25
Medicare Patients
748
Medicare Billing
$152,497
Payment Breakdown by Category
Consulting$13,706 (59.6%)
Other$7,440 (32.3%)
Travel$1,315 (5.7%)
Food & Beverage$546.50 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,706 | 7 | 59.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,440 | 2 | 32.3% |
| Travel and Lodging | $1,315 | 5 | 5.7% |
| Food and Beverage | $546.50 | 11 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $7,261 | 12 | $0 (2024) |
| Eli Lilly and Company | $6,040 | 2 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,400 | 1 | $0 (2024) |
| PFIZER INC. | $1,440 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $1,350 | 1 | $0 (2024) |
| Lilly USA, LLC | $1,308 | 3 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,028 | 1 | $0 (2023) |
| Genentech USA, Inc. | $124.40 | 2 | $0 (2024) |
| ABBVIE INC. | $32.49 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $23.38 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,841 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($4,400) |
| 2023 | $1,028 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($1,028) |
| 2022 | $7,753 | 3 | Eli Lilly and Company ($6,040) |
| 2021 | $4,746 | 2 | Daiichi Sankyo Inc. ($3,596) |
| 2019 | $23.38 | 1 | AstraZeneca Pharmaceuticals LP ($23.38) |
| 2018 | $1,516 | 9 | Daiichi Sankyo Inc. ($1,458) |
| 2017 | $99.98 | 1 | Lilly USA, LLC ($99.98) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $77.91 | General |
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| 08/16/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| Category: Oncology | ||||||
| 07/31/2024 | PFIZER INC. | LORBRENA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $46.49 | General |
| 05/13/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2024 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $470.00 | General |
| 02/22/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $1,027.50 | General |
| Category: Oncology | ||||||
| 10/26/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Consulting Fee | Cash or cash equivalent | $1,712.50 | General |
| Category: ONCOLOGY | ||||||
| 07/14/2022 | Eli Lilly and Company | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| 07/13/2022 | Eli Lilly and Company | — | Travel and Lodging | Cash or cash equivalent | $40.37 | General |
| 10/19/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Consulting Fee | Cash or cash equivalent | $3,596.25 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2021 | Lilly USA, LLC | — | Consulting Fee | Cash or cash equivalent | $1,150.00 | General |
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.38 | General |
| 10/19/2018 | Lilly USA, LLC | CYRAMZA (Drug) | Food and Beverage | In-kind items and services | $58.22 | General |
| Category: Oncology | ||||||
| 10/17/2018 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $57.55 | General |
| 10/17/2018 | Daiichi Sankyo Inc. | — | Food and Beverage | Cash or cash equivalent | $28.56 | General |
| 09/07/2018 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 09/07/2018 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/07/2018 | Daiichi Sankyo Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 09/06/2018 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $909.84 | General |
| 09/06/2018 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $166.40 | General |
| 09/06/2018 | Daiichi Sankyo Inc. | — | Travel and Lodging | In-kind items and services | $140.84 | General |
| 11/30/2017 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $99.98 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 154 | 303 | $77,403 | $35,625 |
| 2022 | 2 | 174 | 338 | $83,635 | $39,910 |
| 2021 | 3 | 184 | 344 | $77,470 | $40,279 |
| 2020 | 3 | 236 | 425 | $91,321 | $36,683 |
Total Patients
748
Total Services
1,410
Medicare Billing
$152,497
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 107 | 256 | $61,277 | $28,904 | 47.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 47 | 47 | $16,126 | $6,721 | 41.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 105 | 269 | $61,119 | $29,823 | 48.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 69 | 69 | $22,516 | $10,087 | 44.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 99 | 251 | $54,095 | $29,318 | 54.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 53 | 53 | $17,225 | $7,853 | 45.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 32 | 40 | $6,150 | $3,107 | 50.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 107 | 266 | $57,190 | $23,150 | 40.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 57 | 57 | $18,525 | $7,265 | 39.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 72 | 102 | $15,606 | $6,268 | 40.2% |
About Dr. Andreas Saltos, M.D
Dr. Andreas Saltos, M.D is a Hematology & Oncology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2012. The National Provider Identifier (NPI) number assigned to this provider is 1679849582.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andreas Saltos, M.D has received a total of $23,008 in payments from pharmaceutical and medical device companies, with $7,841 received in 2024. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($13,706).
As a Medicare-enrolled provider, Saltos has provided services to 748 Medicare beneficiaries, totaling 1,410 services with total Medicare billing of $152,497. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology
- Location Tampa, FL
- Active Since 03/25/2012
- Last Updated 06/11/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1679849582
Products in Payments
- Enhertu (Drug) $3,621
- ENHERTU (Drug) $1,713
- LORBRENA (Drug) $1,440
- RYBREVANT (Drug) $1,350
- Vitrakvi (Drug) $1,028
- CYRAMZA (Drug) $58.22
- IMBRUVICA (Drug) $32.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Tampa
Damian Laber, Md, MD
Hematology & Oncology — Payments: $1.4M
Hematology & Oncology $1.4M
Eduardo Sotomayor, Md, MD
Hematology & Oncology — Payments: $447,992
Hematology & Oncology $447,992
Ariel Grajales-Cruz
Hematology & Oncology — Payments: $424,303
Hematology & Oncology $424,303
Dr. Kendra Sweet, M.d, M.D
Hematology & Oncology — Payments: $215,309
Hematology & Oncology $215,309
Khaldoun Almhanna, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $173,538
Hematology & Oncology $173,538
Hayder Saeed, M.d, M.D
Hematology & Oncology — Payments: $140,365
Hematology & Oncology $140,365